Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ciba Voltaren-XR to cost $2.32 per day AWP; once-daily diclofenac available April 11.

Executive Summary

CIBA VOLTAREN-XR TO BE LAUNCHED APRIL 11 AT $2.32 PER DAY AWP, placing the once-daily formulation of diclofenac sodium in the mid-range of costs for treating arthritis with older diclofenac formulations. Voltaren-XR will cost $232 for 100-count 100 mg tablet bottles. Diclofenac sodium extended-release tablets for chronic therapy of osteoarthritis and rheumatoid arthritis were approved March 8 ("The Pink Sheet" March 18, T&G-1).

Latest Headlines
See All
UsernamePublicRestriction

Register

PS027946

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel